FDA panel weighs moving opioid antidote over the counter

U.S. health advisers on Wednesday were weighing whether the overdose-reversal drug naloxone should be made available as an over-the-counter medication to help fight the national opioid crisis.

from The Washington Times stories: Health https://ift.tt/5rLc9dP

Post a Comment

Previous Post Next Post